The SUNRISE Project is Dedicated to Enhancing Primary Cancer Prevention Among Adolescents in Europe by Leveraging Innovative Digital Tools and Methodologies. SmartCoach, Developed by Swiss Research Institute for Public Health and Addiction (ISGF), is a Mobile Phone-based Life-skills Training Program
Launched by BIOCRUCES BIZKAIA HEALTH RESEARCH INSTITUTE · Apr 9, 2025
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The SUNRISE Project is a research study aimed at preventing cancer in teenagers across eight European countries, including Greece, Switzerland, and Spain. This project focuses on using a mobile phone program called SmartCoach, designed to teach young people valuable life skills that can help them avoid unhealthy behaviors, such as substance use. By integrating digital tools with traditional education, the program hopes to make learning about cancer prevention more engaging and effective, ultimately helping adolescents develop healthy habits that last a lifetime.
To participate in the study, students need to be at least 14 years old and have access to a smartphone and the internet. They will need to provide their own consent and get permission from a parent or guardian. Throughout the study, participants will engage with the SmartCoach program for four months, and their progress will be tracked over 18 months to see how it influences their health behaviors, particularly regarding alcohol and tobacco use. This study is an exciting opportunity for teens to learn how to make healthier choices while contributing to important research that could help reduce cancer risks for future generations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Minimum Age: Students must be at least 14 years old at the time of enrolment.
- • Mobile Device and Internet Access: Students must have access to a smartphone and the Internet.
- • Informed Consent: Students must provide their signed informed consent to participate in the study.
- • Parental Consent: Students must obtain and submit signed informed consent from a parent or legal guardian.
- Exclusion Criteria:
- • Age Restrictions: Students who are younger than 14 years or older than the established age range for participation.
- • Consent Issues: Students who have not signed the informed consent form or do not have signed informed consent from their parents or legal guardians.
- • Follow-up Limitations: Students who are unable to commit to the follow-up period of at least 18 months or are unlikely to complete the study.
About Biocruces Bizkaia Health Research Institute
Biocruces Bizkaia Health Research Institute is a leading research organization based in the Basque Country, Spain, dedicated to advancing health and medical knowledge through innovative clinical trials and research initiatives. With a strong emphasis on multidisciplinary collaboration, the institute focuses on translating scientific discoveries into tangible health solutions, fostering partnerships with academic institutions, healthcare providers, and industry stakeholders. Biocruces Bizkaia is committed to enhancing patient care and outcomes by conducting rigorous clinical research that adheres to the highest ethical and scientific standards. Its comprehensive expertise spans various medical fields, making it a pivotal player in the landscape of health research and innovation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, , Belgium
Nicosia, , Cyprus
Heraklion, , Greece
Roma, , Italy
Cluj Napoca, , Romania
Maribor, , Slovenia
Valencia, , Spain
Zürich, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported